PubMed · 12974799
HLA class I expression in bladder carcinomas.
Abstract
HLA class I molecules are frequently lost in a large variety of human carcinomas, possibly because of T-cell immune selection of major histocompatibility complex class I deficient tumor variants. We report that this phenomenon is also a frequent event in bladder carcinomas. Of a total of 72 bladder carcinomas, 72% of the tumors had at least one alteration in HLA class I expression. These altered HLA class I phenotypes were classified as total HLA class I loss (25%; phenotype I); HLA-A or/and HLA-B locus-specific loss (12%; phenotype III); and HLA class I allelic loss (35%; phenotype II or IV). Comparison of histopathological parameters with HLA class I expression showed a statistically significant relationship with the degree of differentiation and tumor recurrence.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
T Cabrera, G Pedrajas, J M Cozar, A Garrido, J Vicente, M Tallada, F Garrido. 2003. HLA class I expression in bladder carcinomas.. https://doi.org/10.1034/j.1399-0039.2003.00104.x. https://pubmed.health/record/pubmed%3A12974799/hla-class-i-expression-in-bladder-carcinomas
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.